Protein Kinase Inhibitors: all 15,278 studies that test it
Page 104 of 153. Open to participants first (2,556), then studies with results posted, then the rest; newest registration first within each.
- Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of ASK120067 in Locally Advanced and Metastatic Non Small Cell Lung CancerStatus unknownNCT03502850Phase 1/2
- Testing the Combination of Copanlisib, Nivolumab and Ipilimumab in Patients With Advanced Cancer and LymphomaActive, not recruitingNCT03502733Phase 1
- Study of Trametinib + Ceritinib in Patients With Unresectable MelanomaCompletedNCT03501368Phase 1
- Sirolimus-based Immunosuppression Treatment Regimen for Liver TransplantationStatus unknownNCT03500848Phase 2/3
- Efficacy and Safety of Rapamycin (Sirolimus) in the Treatment of Symptomatic Uterine Fibroids and LeiomyomatosisStatus unknownNCT03500367Phase 4
- Phase 1b of ASLAN001 (Varlitinib) in Patients With Advanced/ Metastatic Hepatocellular Carcinoma (HCC)Status unknownNCT03499626Phase 1/2
- Copanlisib Chinese PK StudyCompletedNCT03498430Phase 1
- Avelumab, Cetuximab, and Palbociclib in Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaActive, not recruitingNCT03498378Phase 1
- The Effect of Itraconazole on BCT197 Exposure in Healthy Male ParticipantsCompletedNCT03498170Phase 1
- A Randomised Phase II Trial of Osimertinib With or Without SRS for EGFR Mutated NSCLC With Brain MetastasesCompletedNCT03497767Phase 2
- Safety of Itacitinib in Combination With Corticosteroids for Treatment of Steroid-Naive Acute Graft-Versus-Host Disease in Japanese SubjectsCompletedNCT03497273Phase 1
- A Study to Evaluate ICP-022 in Patients With R/R Mantle Cell Lymphoma (MCL)CompletedNCT03494179Phase 1/2
- A Multiple Dose Study of BAY1834845 in Healthy Male Subjects and in Patients With PsoriasisCompletedNCT03493269Phase 1
- A Study to Evaluate ICP-022 in Patients With CLL/ SLLStatus unknownNCT03493217Phase 1/2
- Phase I Study of SHR9146 + SHR-1210 +/- Apatinib in Patients With Advanced Solid TumorsStatus unknownNCT03491631Phase 1
- Development of Ursodeoxycholic Acid 300 mg at Hospital Das Clinicas of the University of São Paulo School of MedicineCompletedNCT03489889Not applicable
- Afatinib Plus Chemotherapy Against Esophageal or Lung Squamous Cell CarcinomaStatus unknownNCT03486509Phase 2
- Gefitinib and Berberine in the First-line Treatment of Lung Adenocarcinoma With EGFR MutationStatus unknownNCT03486496Phase 2
- Rogaratinib (BAY1163877) Human Mass Balance StudyCompletedNCT03484585Phase 1
- A Study of Venetoclax and Dinaciclib (MK7965) in Patients With Relapsed/Refractory Acute Myeloid LeukemiaTerminatedNCT03484520Phase 1
- Phase I Study of HMPL-523+Azacitidine in Elderly Patients With Acute Myeloid LeukemiaTerminatedNCT03483948Phase 1
- A Study of SHR6390 in Combination With Letrozole or Anastrozole or Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast CancerCompletedNCT03481998Phase 1/2
- Safety, Tolerability and Efficacy of Vaginal Suppositories for Treatment of the EndometriosisWithdrawnNCT03481842Phase 1/2
- Study to Evaluate SHR6390 Combined With Pyrotinib in Patients With HER2 Positive Gastric CancerStatus unknownNCT03480256Phase 1
- Study of PAN-90806 Eye Drops, Suspension for Neovascular AMDCompletedNCT03479372Phase 1/2
- Pevonedistat and Ibrutinib in Treating Participants With Relapsed or Refractory CLL or Non-Hodgkin LymphomaActive, not recruitingNCT03479268Phase 1
- Phase II Palbociclib +Ibrutinib in Mantle Cell LymphomaActive, not recruitingNCT03478514Phase 2
- Oral AQX-1125 and Combination Oral Contraceptive Drug-Drug Interaction StudyCompletedNCT03478020Phase 1
- Study on the Adverse Drug Reactions (ADRs) of Apatinib and Their Biomarker CorrelationsStatus unknownNCT03475589Phase 4
- Copanlisib and Rituximab in Marginal Zone Lymphoma PatientsActive, not recruitingNCT03474744Phase 2
- Palbociclib and Dexamethasone in Treating Participants With Relapsed or Refractory B-Cell Acute Lymphoblastic LeukemiaCompletedNCT03472573Phase 1
- Safety and Efficacy Study of Tenalisib (RP6530) in Combination With Pembrolizumab in Relapsed or Refractory cHLTerminatedNCT03471351Phase 1
- Galunisertib and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal CancerWithdrawnNCT03470350Phase 1/2
- A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer.TerminatedNCT03469011Phase 1
- Study to Evaluate the Safety and Anti-tumor Activity of SCC244CompletedNCT03466268Phase 1
- Safety and Pharmacokinetics of Zanubrutinib (BGB-3111) in Healthy Subjects and Those With Impaired Liver FunctionCompletedNCT03465059Phase 1
- A Study of CaBozantinib in Patients With Advanced or Unresectable Renal cEll cArcinomaCompletedNCT03463681Phase 2
- Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or Unresectable Thymic CancerActive, not recruitingNCT03463460Phase 2
- Combination ATR and PARP Inhibitor (CAPRI) Trial With AZD6738 and Olaparib in Recurrent Ovarian CancerCompletedNCT03462342Phase 2
- Randomized Comparative Study of Erlotinib and Pemetrexed in the Maintenance Treatment of Advanced Lung Cancer Patients.TerminatedNCT03460678Phase 4
- Osimertinib as First-line Therapy for Patients With Late-stage Lung CancerStatus unknownNCT03460275Phase 2
- A Study of Anlotinib in Patients With Gastroenteropancreatic Neuroendocrine Tumor G3Status unknownNCT03457844Phase 2
- A Phase I Study of SCC244 in Patients with Advanced MET Alterations Solid TumorsCompletedNCT03457532Phase 1
- Clinical Study of Apatinib Combined With SBRT Therapy in the Treatment of Oligometastasis of Breast CancerStatus unknownNCT03457467Phase 2
- S-1 Plus Gefitinib Versus Gefitinib Monotherapy in Patients With EGFR-sensitive Mutation Advanced Non-squamous NSCLCStatus unknownNCT03457337Phase 2
- Efficacy of Palbociclib in Advanced Acral Melanoma With Cell Cycle Gene AberrationsStatus unknownNCT03454919Phase 2
- Efficacy and Safety of Alflutinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer Patients With T790MTerminatedNCT03452592Phase 2
- D-0316 First Time in Patients Ascending Dose StudyCompletedNCT03452150Phase 1
- Assessing an Oral Janus Kinase Inhibitor, AZD4205, in Combination With Osimertinib in Patients Who Have Advanced Non-small Cell Lung CancerCompletedNCT03450330Phase 1/2
- Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines (Style Trial)Status unknownNCT03449173Phase 2
- Daratumumab and Ibrutinib in Treating Patients With Symptomatic Chronic Lymphocytic LeukemiaCompletedNCT03447808Phase 1
- Fulvestrant Versus Fulvestrant Plus Palbociclib in Operable Breast Cancer Responding to FulvestrantCompletedNCT03447132Phase 3
- A Study of ZN-e4 in Subjects With Epidermal Growth Factor Receptor Mutated Non-Small Cell Lung CancerCompletedNCT03446417Phase 1
- To Evaluate the Safety, Tolerability and Pharmacokinetics of K0706 in Plasma and Cerebrospinal Fluid in Healthy VolunteersCompletedNCT03445338Phase 1
- A Study of Venetoclax and Alvocidib in Patients With Relapsed/Refractory Acute Myeloid LeukemiaCompletedNCT03441555Phase 1
- Extended Access of Momelotinib in Adults With MyelofibrosisActive, not recruitingNCT03441113Phase 2
- Avelumab, Utomilumab, Rituximab, Ibrutinib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell LymphomaCompletedNCT03440567Phase 1
- PF-06463922 for Crizotinib Pretreated ROS1 Positive Non-small-cell Lung CancerStatus unknownNCT03439215Phase 2
- Prior Axitinib as a Determinant of Outcome of Renal SurgeryActive, not recruitingNCT03438708Phase 2
- Effect of Renal Impairment on Evobrutinib Pharmacokinetics (PK)CompletedNCT03436394Phase 1
- Effect of Neflamapimod on Brain Inflammation in Alzheimer's Disease PatientsCompletedNCT03435861Phase 2
- SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain TumorsCompletedNCT03434262Phase 1
- A Two-Part Phase 1 Study to Investigate the Safety and Tolerability of Supratherapeutic Dose of Zanubrutinib and Effect of Zanubrutinib on Cardiac Repolarization in Healthy SubjectsCompletedNCT03432884Phase 1
- Vemurafenib Plus Cobimetinib After Radiosurgery in Patients With BRAF-mutant Melanoma Brain MetastasesTerminatedNCT03430947Phase 2
- Sapanisertib, Carboplatin, and Paclitaxel in Treating Patients With Recurrent or Refractory Malignant Solid TumorsCompletedNCT03430882Phase 1
- DAY101 In Gliomas and Other TumorsCompletedNCT03429803Phase 1
- First-in-human Study of Oral TP-0184 in Patients With Advanced Solid TumorsCompletedNCT03429218Phase 1
- A Study of Poziotinib in Combination With T-DM1 in HER2-Positive Breast CancerTerminatedNCT03429101Phase 1
- Study of AZD6738 and Olaparib Combination Therapy in Relapsed Small Cell Lung Cancer Patients [SUKSES-N2]CompletedNCT03428607Phase 2
- Apatinib for Advanced Biliary CarcinomaStatus unknownNCT03427242Phase 2
- Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast CancerActive, not recruitingNCT03425838Phase 3
- Niraparib in Combination with Cabozantinib (XL184) in Patients with Advanced Urothelial Cancer (NICARAGUA)CompletedNCT03425201Phase 1/2
- Uncommon EGFR AZD9291Status unknownNCT03424759Phase 2
- A Study to Evaluate the Food-Effect of H3B-6527CompletedNCT03424577Phase 1
- A Retrospective Clinical Study of Apatinib in Combination With Radiotherapy / Chemotherapy Second-line and Above in the Treatment of Recurrent / Metastatic Head and Neck Squamous Cell CarcinomaStatus unknownNCT03424291Phase 2
- INCB050465 in Combination With Rituximab, Bendamustine and Rituximab, or Ibrutinib in Participants With Previously Treated B-Cell Lymphoma (CITADEL-112)CompletedNCT03424122Phase 1
- A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain CancerCompletedNCT03423628Phase 1
- PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studYActive, not recruitingNCT03423199Phase 3
- Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic DermatitisCompletedNCT03422822Phase 3
- A Study of Apatinib Combined With Temozolomide in Patients Witn Advanced MelanomaStatus unknownNCT03422445Phase 2
- Venetoclax With High-dose Ibrutinib for CLL Progressing on Single Agent IbrutinibActive, not recruitingNCT03422393Phase 1
- Stem Cell Transplant in Patients With Severe Sickle Cell DiseaseTerminatedNCT03421756Early Phase 1
- Treating Patients With Melanoma and ALK Alterations With EnsartinibActive, not recruitingNCT03420508Phase 2
- A Phase I Study of FCN-411 in Advanced Non-small Cell Lung Cancer Chinese Patients With EGFR Positive MutationStatus unknownNCT03420079Phase 1/2
- An Investigational Study of Cyclosporine on Experimental Medication BMS-986165 in Healthy Male ParticipantsCompletedNCT03419910Phase 1
- Anlotinib and Irinotecan for Ewing SarcomaStatus unknownNCT03416517Phase 1/2
- Apatinib Plus Docetaxel in Advanced Non-squamous Non-small Cell Lung Cancer(NSCLC)Status unknownNCT03416231Phase 2
- Everolimus and Tacrolimus Combination for Regression of Left Ventricular Hypertrophy in Renal TransplantsCompletedNCT03415750Phase 4
- A Study of ASN007 in Patients With Advanced Solid TumorsCompletedNCT03415126Phase 1
- Evaluation of ETC-1907206 With Dasatinib in Advanced Haematologic MalignanciesWithdrawnNCT03414450Phase 1
- Clinical Study of Apatinib Combined With Second - Line Chemotherapy for Metastatic Colorectal CancerStatus unknownNCT03412994Phase 2
- Pyrotinib in Metastatic HER2 Non-amplified But HER2 Mutant Breast CancerStatus unknownNCT03412383Phase 2
- MAX-40279 in Subjects With Acute Myelogenous Leukemia (AML)Status unknownNCT03412292Phase 1
- Apatinib in Combination With Docetaxel for Patients With Advanced NSCLCStatus unknownNCT03411967Phase 2
- A Study of TAS0728 in Patients With Solid Tumors With HER2 or HER3 AbnormalitiesTerminatedNCT03410927Phase 1
- A Phase II Study of the BRAF Inhibitor, Vemurafenib, Plus Obinutuzumab in Patients With Previously Untreated Classical Hairy Cell LeukemiaActive, not recruitingNCT03410875Phase 2
- Osimertinib, Surgery, and Radiation Therapy in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer With EGFR Mutations, NORTHSTAR StudyActive, not recruitingNCT03410043Phase 2
- TD-1473 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male SubjectsCompletedNCT03408470Phase 1
- Apatinib With Pembrolizumab in Previously Treated Advanced MalignanciesTerminatedNCT03407976Phase 1
- Apatinib in the Treatment of Metastatic Colorectal CancerStatus unknownNCT03403452Phase 2